168 related articles for article (PubMed ID: 21442242)
21. Combination of Magnetic Resonance Spectroscopy and ¹¹C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma.
Kudulaiti N; Qiu T; Lu J; Zhang H; Zhang Z; Guan Y; Zhuang D; Wu J
Korean J Radiol; 2019 Jun; 20(6):967-975. PubMed ID: 31132822
[TBL] [Abstract][Full Text] [Related]
22. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.
Tripathi M; Sharma R; Varshney R; Jaimini A; Jain J; Souza MM; Bal J; Pandey S; Kumar N; Mishra AK; Mondal A
Clin Nucl Med; 2012 Feb; 37(2):158-63. PubMed ID: 22228339
[TBL] [Abstract][Full Text] [Related]
23. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
24. Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
Imani F; Boada FE; Lieberman FS; Davis DK; Deeb EL; Mountz JM
J Neuroimaging; 2012 Apr; 22(2):184-90. PubMed ID: 21155917
[TBL] [Abstract][Full Text] [Related]
25. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
26. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
[TBL] [Abstract][Full Text] [Related]
27. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
[TBL] [Abstract][Full Text] [Related]
28. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
29. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.
Kwee SA; Coel MN; Lim J; Ko JP
J Neuroimaging; 2004 Jul; 14(3):285-9. PubMed ID: 15228773
[TBL] [Abstract][Full Text] [Related]
30. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
[TBL] [Abstract][Full Text] [Related]
31. Molecular and metabolic pattern classification for detection of brain glioma progression.
Imani F; Boada FE; Lieberman FS; Davis DK; Mountz JM
Eur J Radiol; 2014 Feb; 83(2):e100-5. PubMed ID: 24321226
[TBL] [Abstract][Full Text] [Related]
32. 11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
Yamamoto Y; Nishiyama Y; Kimura N; Kameyama R; Kawai N; Hatakeyama T; Kaji M; Ohkawa M
Mol Imaging Biol; 2008 Sep; 10(5):281-7. PubMed ID: 18543041
[TBL] [Abstract][Full Text] [Related]
33. [Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy].
Suzuki A; Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1996 May; 48(5):449-57. PubMed ID: 8672304
[TBL] [Abstract][Full Text] [Related]
34. [Application of 1H-magnetic resonance spectroscopy in differential diagnosis of brain low-grade gliomas and demyelinating diseases].
Hou XY; Gao PY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):206-9. PubMed ID: 19507601
[TBL] [Abstract][Full Text] [Related]
35. Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours.
Huang Z; Zuo C; Guan Y; Zhang Z; Liu P; Xue F; Lin X
Nucl Med Commun; 2008 Apr; 29(4):354-8. PubMed ID: 18317300
[TBL] [Abstract][Full Text] [Related]
36. (11)C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas.
Okita Y; Nonaka M; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Nakajima S; Kanemura Y
Clin Neurol Neurosurg; 2014 Oct; 125():212-6. PubMed ID: 25178915
[TBL] [Abstract][Full Text] [Related]
37. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
38. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
39. Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
Go KG; Kamman RL; Mooyaart EL; Heesters MA; Pruim J; Vaalburg W; Paans AM
Neuroradiology; 1995 Apr; 37(3):198-206. PubMed ID: 7603595
[TBL] [Abstract][Full Text] [Related]
40. An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using
Takahashi M; Soma T; Mukasa A; Koyama K; Arai T; Momose T
Ann Nucl Med; 2017 Apr; 31(3):250-259. PubMed ID: 28194701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
